DCAF10
gene geneOn this page
Also known as MGC10765FLJ23201
Summary
DCAF10 (DDB1 and CUL4 associated factor 10, HGNC:23686) is a protein-coding gene on chromosome 9p13.2, encoding DDB1- and CUL4-associated factor 10 (Q5QP82). May function as a substrate receptor for CUL4-DDB1 E3 ubiquitin-protein ligase complex.
Predicted to be involved in protein ubiquitination. Part of Cul4-RING E3 ubiquitin ligase complex.
Source: NCBI Gene 79269 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 57 total
- MANE Select transcript:
NM_024345
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23686 |
| Approved symbol | DCAF10 |
| Name | DDB1 and CUL4 associated factor 10 |
| Location | 9p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC10765, FLJ23201 |
| Ensembl gene | ENSG00000122741 |
| Ensembl biotype | protein_coding |
| OMIM | 620295 |
| Entrez | 79269 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 6 protein_coding, 3 protein_coding_CDS_not_defined
ENST00000242323, ENST00000377724, ENST00000461549, ENST00000478453, ENST00000483167, ENST00000878417, ENST00000878418, ENST00000878419, ENST00000878420
RefSeq mRNA: 2 — MANE Select: NM_024345
NM_001286810, NM_024345
CCDS: CCDS6613, CCDS75835
Canonical transcript exons
ENST00000377724 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001418498 | 37819288 | 37819401 |
| ENSE00001433066 | 37842089 | 37842286 |
| ENSE00001836891 | 37800797 | 37801405 |
| ENSE00003462136 | 37854780 | 37854982 |
| ENSE00003514965 | 37861140 | 37867664 |
| ENSE00003516403 | 37857241 | 37857351 |
| ENSE00003658919 | 37860048 | 37860193 |
Expression profiles
Bgee: expression breadth ubiquitous, 281 present calls, max score 98.37.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 18.4996 / max 112.1127, expressed in 1809 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 96747 | 18.4996 | 1809 |
Top tissues by expression
292 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 98.37 | gold quality |
| male germ cell | CL:0000015 | 94.16 | gold quality |
| left testis | UBERON:0004533 | 92.99 | gold quality |
| adrenal tissue | UBERON:0018303 | 92.41 | gold quality |
| right testis | UBERON:0004534 | 92.35 | gold quality |
| stromal cell of endometrium | CL:0002255 | 91.73 | gold quality |
| testis | UBERON:0000473 | 91.38 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 90.57 | gold quality |
| islet of Langerhans | UBERON:0000006 | 90.46 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 90.01 | gold quality |
| gastrocnemius | UBERON:0001388 | 88.46 | gold quality |
| cartilage tissue | UBERON:0002418 | 88.27 | gold quality |
| muscle of leg | UBERON:0001383 | 88.01 | gold quality |
| right adrenal gland | UBERON:0001233 | 87.94 | gold quality |
| adrenal gland | UBERON:0002369 | 87.52 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 87.35 | gold quality |
| adult organism | UBERON:0007023 | 87.28 | gold quality |
| left adrenal gland | UBERON:0001234 | 87.27 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 87.00 | gold quality |
| adrenal cortex | UBERON:0001235 | 86.48 | gold quality |
| rectum | UBERON:0001052 | 86.46 | gold quality |
| ganglionic eminence | UBERON:0004023 | 86.43 | gold quality |
| cortical plate | UBERON:0005343 | 86.31 | gold quality |
| pancreas | UBERON:0001264 | 86.26 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 85.95 | gold quality |
| skeletal muscle organ | UBERON:0014892 | 85.69 | gold quality |
| muscle organ | UBERON:0001630 | 85.68 | gold quality |
| esophagus mucosa | UBERON:0002469 | 85.35 | gold quality |
| body of pancreas | UBERON:0001150 | 85.24 | gold quality |
| mammary duct | UBERON:0001765 | 85.13 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-6819 | yes | 3995.96 |
| E-ANND-3 | yes | 9.26 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
288 targeting DCAF10, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-518D-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-518E-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-518F-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-519A-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-519B-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-519C-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-520C-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-522-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-523-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-526A-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-6758-5P | 100.00 | 66.21 | 1470 |
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-6856-5P | 100.00 | 65.47 | 1298 |
| HSA-MIR-4668-3P | 100.00 | 68.74 | 2635 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-4510 | 100.00 | 66.60 | 2050 |
| HSA-MIR-6127 | 100.00 | 66.76 | 2188 |
| HSA-MIR-6129 | 100.00 | 66.46 | 2080 |
| HSA-MIR-6130 | 100.00 | 66.69 | 2012 |
| HSA-MIR-6133 | 100.00 | 66.48 | 2064 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-3689D | 100.00 | 66.14 | 1181 |
| HSA-MIR-6851-5P | 100.00 | 65.63 | 1294 |
| HSA-MIR-4283 | 100.00 | 66.42 | 2097 |
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-4476 | 100.00 | 68.18 | 2030 |
| HSA-MIR-6876-5P | 100.00 | 67.68 | 2126 |
| HSA-MIR-4673 | 100.00 | 66.64 | 1490 |
Literature-anchored findings (GeneRIF, showing 1)
- Adenovirus E1A binding to DCAF10 targets proteasomal degradation of RUVBL1/2 AAA+ ATPases required for quaternary assembly of multiprotein machines, innate immunity, and responses to metabolic stress. (PMID:37962355)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | wdr32 | ENSDARG00000029600 |
| mus_musculus | Dcaf10 | ENSMUSG00000035572 |
| rattus_norvegicus | Dcaf10 | ENSRNOG00000011655 |
| drosophila_melanogaster | CG1523 | FBGN0039601 |
Protein
Protein identifiers
DDB1- and CUL4-associated factor 10 — Q5QP82 (reviewed: Q5QP82)
Alternative names: WD repeat-containing protein 32
All UniProt accessions (2): A0A0A0MQT4, Q5QP82
UniProt curated annotations — full annotation on UniProt →
Function. May function as a substrate receptor for CUL4-DDB1 E3 ubiquitin-protein ligase complex.
Subunit / interactions. Interacts with DDB1.
Pathway. Protein modification; protein ubiquitination.
Similarity. Belongs to the WD repeat DCAF10 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5QP82-1 | 1 | yes |
| Q5QP82-2 | 2 |
RefSeq proteins (2): NP_001273739, NP_077321* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001680 | WD40_rpt | Repeat |
| IPR015943 | WD40/YVTN_repeat-like_dom_sf | Homologous_superfamily |
| IPR036322 | WD40_repeat_dom_sf | Homologous_superfamily |
| IPR039085 | DCA10 | Family |
Pfam: PF00400
UniProt features (24 total): repeat 7, modified residue 6, compositionally biased region 4, sequence conflict 3, region of interest 2, chain 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5QP82-F1 | 70.93 | 0.44 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (6): 53, 63, 89, 92, 134, 349
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-8951664 | Neddylation |
MSigDB gene sets: 156 (showing top):
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_UP, GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_DN, CGGAARNGGCNG_UNKNOWN, IVANOVA_HEMATOPOIESIS_MATURE_CELL, SMID_BREAST_CANCER_LUMINAL_B_UP, chr9p13, MODULE_480, GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN, MODULE_427, GOCC_TRANSFERASE_COMPLEX, MODULE_192, GOCC_CUL4_RING_E3_UBIQUITIN_LIGASE_COMPLEX, GOCC_CULLIN_RING_UBIQUITIN_LIGASE_COMPLEX, SCGGAAGY_ELK1_02
GO Biological Process (1): protein ubiquitination (GO:0016567)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): nucleoplasm (GO:0005654), Cul4-RING E3 ubiquitin ligase complex (GO:0080008)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Post-translational protein modification | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein modification by small protein conjugation | 1 |
| binding | 1 |
| nuclear lumen | 1 |
| cellular anatomical structure | 1 |
| cullin-RING ubiquitin ligase complex | 1 |
Protein interactions and networks
STRING
1152 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DCAF10 | C17orf75 | Q9HAS0 | 573 |
| DCAF10 | C1GALT1C1L | P0DN25 | 555 |
| DCAF10 | DCAF5 | Q96JK2 | 533 |
| DCAF10 | CYP20A1 | Q6UW02 | 514 |
| DCAF10 | DCAF4 | Q8WV16 | 509 |
| DCAF10 | NUDT12 | Q9BQG2 | 502 |
| DCAF10 | KLHDC10 | Q6PID8 | 491 |
| DCAF10 | DYNC2H1 | Q8NCM8 | 479 |
| DCAF10 | CIAO1 | O76071 | 476 |
| DCAF10 | FKBP14 | Q9NWM8 | 474 |
| DCAF10 | CACNG8 | Q8WXS5 | 474 |
| DCAF10 | SYNJ2BP | P57105 | 461 |
| DCAF10 | FRMPD1 | Q5SYB0 | 458 |
| DCAF10 | RAB3IP | Q96QF0 | 437 |
| DCAF10 | SAYSD1 | Q9NPB0 | 431 |
IntAct
119 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CUL4B | COPS2 | psi-mi:“MI:0914”(association) | 0.790 |
| COPS6 | RHOBTB1 | psi-mi:“MI:0914”(association) | 0.730 |
| PPP2R2C | PPP2R1A | psi-mi:“MI:0914”(association) | 0.730 |
| CUL4A | COPS2 | psi-mi:“MI:0914”(association) | 0.640 |
| SLX4 | ERCC1 | psi-mi:“MI:0914”(association) | 0.640 |
| EIF3I | EIF3CL | psi-mi:“MI:0914”(association) | 0.640 |
| PPP2R2C | TCP1 | psi-mi:“MI:0914”(association) | 0.640 |
| CCT3 | TXNDC9 | psi-mi:“MI:0914”(association) | 0.640 |
| EIF3I | EIF3F | psi-mi:“MI:0914”(association) | 0.640 |
| NDUFAF4 | NDUFS8 | psi-mi:“MI:0914”(association) | 0.640 |
| SPG11 | AP5Z1 | psi-mi:“MI:0914”(association) | 0.620 |
| DCAF10 | LHX4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DCAF10 | DNAJA2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TCIRG1 | AP3D1 | psi-mi:“MI:0914”(association) | 0.530 |
| TNFRSF13B | TNFRSF10B | psi-mi:“MI:0914”(association) | 0.530 |
| SPINK4 | PLXNA2 | psi-mi:“MI:0914”(association) | 0.530 |
| ZMAT5 | DENND4B | psi-mi:“MI:0914”(association) | 0.530 |
| TRUB2 | HSPD1 | psi-mi:“MI:0914”(association) | 0.530 |
| STK16 | FLG | psi-mi:“MI:0914”(association) | 0.530 |
| SLAIN1 | HSPA9 | psi-mi:“MI:0914”(association) | 0.530 |
| GNAZ | MTHFR | psi-mi:“MI:0914”(association) | 0.530 |
| DIRAS3 | MTIF2 | psi-mi:“MI:0914”(association) | 0.530 |
| PPIL2 | YWHAH | psi-mi:“MI:0914”(association) | 0.530 |
| FBXL19 | MED19 | psi-mi:“MI:0914”(association) | 0.530 |
| HSPB8 | VWA8 | psi-mi:“MI:0914”(association) | 0.530 |
| YJU2B | RCCD1 | psi-mi:“MI:0914”(association) | 0.530 |
| STK16 | UNC119B | psi-mi:“MI:0914”(association) | 0.530 |
BioGRID (268): DCAF10 (Affinity Capture-MS), DCAF10 (Affinity Capture-MS), DCAF10 (Affinity Capture-MS), DCAF10 (Affinity Capture-MS), DCAF10 (Affinity Capture-MS), DCAF10 (Affinity Capture-MS), DCAF10 (Affinity Capture-MS), DCAF10 (Affinity Capture-MS), DCAF10 (Affinity Capture-MS), DCAF10 (Biochemical Activity), DCAF10 (Affinity Capture-MS), DCAF10 (Affinity Capture-MS), DCAF10 (Affinity Capture-MS), DCAF10 (Affinity Capture-MS), DCAF10 (Affinity Capture-MS)
ESM2 similar proteins: A2AKB9, A2RRH5, A2RRU4, A2SXS5, A6QM06, O60346, O88559, P30291, P97260, Q08BB3, Q0P5I0, Q12770, Q3B7L5, Q3MHH0, Q3UHE1, Q4R3J7, Q5E9I8, Q5FW06, Q5M9G8, Q5MNU5, Q5QP82, Q5R7H5, Q5T6F0, Q5VW00, Q5ZJL7, Q63ZP7, Q69Z89, Q6AX81, Q6GQT6, Q6NS60, Q6NWH1, Q6P809, Q6ZWB6, Q8AVS9, Q8BGW4, Q8BGZ3, Q8CHE4, Q8NHY2, Q8QZS3, Q8TEB1
Diamond homologs: A2AKB9, B4JSW8, B4M4W4, C7Z6H2, O14021, Q4ICM0, Q4PSE4, Q5FW06, Q5QP82, Q5RHI5, Q6NWH1, Q8AVS9, Q9VAT2, A7RHG8, B2AEZ5, B2B766, B4JPT9, B9WD30, C4YPI7, C5MJE8, O22466, O22467, O22468, O22469, O93377, O94244, P0CS36, P0CS37, P39984, P90916, Q03897, Q09028, Q10G81, Q16576, Q24572, Q2HBX6, Q2UA71, Q3MHL3, Q3SWX8, Q4I7L0
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 154 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| DNA Damage Recognition in GG-NER | 8 | 23.6× | 8e-07 |
| Formation of TC-NER Pre-Incision Complex | 6 | 13.1× | 2e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
57 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 49 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2159 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:37819287:GGTCA:G | acceptor_gain | 1.0000 |
| 9:37860191:G:GT | donor_gain | 1.0000 |
| 9:37861138:A:AG | acceptor_gain | 1.0000 |
| 9:37861139:G:GG | acceptor_gain | 1.0000 |
| 9:37861139:GT:G | acceptor_gain | 1.0000 |
| 9:37861139:GTGT:G | acceptor_gain | 1.0000 |
| 9:37861139:GTGTA:G | acceptor_gain | 1.0000 |
| 9:37801401:GACGG:G | donor_gain | 0.9900 |
| 9:37801404:GG:G | donor_gain | 0.9900 |
| 9:37801404:GGGTA:G | donor_loss | 0.9900 |
| 9:37801405:GG:G | donor_gain | 0.9900 |
| 9:37801406:GTAA:G | donor_loss | 0.9900 |
| 9:37801407:T:TC | donor_loss | 0.9900 |
| 9:37831490:AGTT:A | donor_gain | 0.9900 |
| 9:37842171:G:GG | donor_gain | 0.9900 |
| 9:37857239:A:G | acceptor_gain | 0.9900 |
| 9:37860047:GGA:G | acceptor_gain | 0.9900 |
| 9:37860299:GGCA:G | donor_gain | 0.9900 |
| 9:37861136:CTAGT:C | acceptor_loss | 0.9900 |
| 9:37861138:AGT:A | acceptor_gain | 0.9900 |
| 9:37861139:G:GT | acceptor_loss | 0.9900 |
| 9:37861139:GTG:G | acceptor_gain | 0.9900 |
| 9:37801406:G:GG | donor_gain | 0.9800 |
| 9:37819397:ATCAG:A | donor_loss | 0.9800 |
| 9:37819398:TCAG:T | donor_loss | 0.9800 |
| 9:37819399:CAG:C | donor_loss | 0.9800 |
| 9:37819400:AG:A | donor_loss | 0.9800 |
| 9:37819401:GGTT:G | donor_loss | 0.9800 |
| 9:37819402:G:GC | donor_loss | 0.9800 |
| 9:37819403:T:A | donor_loss | 0.9800 |
AlphaMissense
3572 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:37801380:T:C | F172L | 1.000 |
| 9:37801382:C:A | F172L | 1.000 |
| 9:37801382:C:G | F172L | 1.000 |
| 9:37801392:T:G | Y176D | 1.000 |
| 9:37801404:G:A | G180R | 1.000 |
| 9:37801404:G:C | G180R | 1.000 |
| 9:37801404:G:T | G180W | 1.000 |
| 9:37801405:G:A | G180E | 1.000 |
| 9:37801405:G:T | G180V | 1.000 |
| 9:37819296:T:C | L183P | 1.000 |
| 9:37819326:T:C | L193P | 1.000 |
| 9:37819329:T:C | L194P | 1.000 |
| 9:37819393:T:A | N215K | 1.000 |
| 9:37819393:T:G | N215K | 1.000 |
| 9:37842090:T:C | F219L | 1.000 |
| 9:37842091:T:C | F219S | 1.000 |
| 9:37842092:T:A | F219L | 1.000 |
| 9:37842092:T:G | F219L | 1.000 |
| 9:37842109:T:C | F225S | 1.000 |
| 9:37842112:C:A | A226D | 1.000 |
| 9:37842119:C:G | C228W | 1.000 |
| 9:37842120:T:C | S229P | 1.000 |
| 9:37842121:C:A | S229Y | 1.000 |
| 9:37842121:C:T | S229F | 1.000 |
| 9:37842123:G:C | D230H | 1.000 |
| 9:37842124:A:C | D230A | 1.000 |
| 9:37842124:A:G | D230G | 1.000 |
| 9:37842124:A:T | D230V | 1.000 |
| 9:37842126:G:C | D231H | 1.000 |
| 9:37842126:G:T | D231Y | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000019794 (9:37831873 G>A), RS1000111989 (9:37865634 G>C), RS1000160190 (9:37810982 G>A,C), RS1000172251 (9:37840220 A>G), RS1000179746 (9:37818642 C>T), RS1000204844 (9:37840619 G>A), RS1000221404 (9:37824305 C>T), RS1000313758 (9:37802759 A>G), RS1000452317 (9:37848421 A>G), RS1000504888 (9:37863422 A>C), RS1000526253 (9:37822156 A>C,G), RS1000609190 (9:37855070 A>G), RS1000695952 (9:37836954 A>G), RS1000697103 (9:37819741 T>C,G), RS1000758227 (9:37811824 G>A)
Disease associations
OMIM: gene MIM:620295 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003772_13 | Loneliness (linear analysis) | 2.000000e-06 |
| GCST90002385_381 | High light scatter reticulocyte count | 3.000000e-09 |
| GCST90002405_457 | Reticulocyte count | 2.000000e-09 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007865 | loneliness measurement |
| EFO:0007986 | reticulocyte count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
25 total (human), top 25 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases expression | 4 |
| Air Pollutants | increases expression, decreases expression, increases abundance | 2 |
| Particulate Matter | decreases expression, increases abundance, increases expression | 2 |
| GSK-J4 | increases expression | 1 |
| FR900359 | affects phosphorylation | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| trichostatin A | increases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| coumarin | increases phosphorylation | 1 |
| ICG 001 | increases expression | 1 |
| abrine | increases expression | 1 |
| jinfukang | decreases expression | 1 |
| Sunitinib | increases expression | 1 |
| Leflunomide | increases expression | 1 |
| Atrazine | increases expression | 1 |
| Caffeine | decreases phosphorylation | 1 |
| Carbamazepine | affects expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.